RecruitingNCT07643610

BEAT-SHOCK Registry

BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry

Sponsor

University Hospital, Basel, Switzerland

Enrollment

8,000 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Cardiogenic Shock Myocardial Infarction (MI)Acute Decompensated Heart Failure Fulminant Myocarditis Severe Valvular Disease Post-cardiotomy Perioperative Cardiogenic Shock

Summary

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying no internvention for people with acute decompensated heart failure, cardiogenic shock, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno internvention

This is a health data registry.

Locations(1)

University Hospital Basel

Basel, Canton of Basel-City, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07643610

Related Trials

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE

NCT075155084 locations

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

NCT0702789112 locations